Published: Diabetes Technology & Therapeutics
Date:
Authors: Mary E Larkin 1 , David M Nathan 1 , Ionut Bebu 2 , Heidi Krause-Steinrauf 2 , William H Herman 3 , John M Higgins 4 5 , Margaret Tiktin 6 , Robert M Cohen 7 , Claire Lund 2 , Richard M Bergenstal 8 , Mary L Johnson 8 , Valerie Arends 9 , GRADE Research Group
Abstract:
The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study has enrolled a racially and ethnically diverse population with type 2 diabetes, performed extensive phenotyping, and randomly assigned the participants to one of four second-line diabetes medications.
Published: Pan American Journal of Public Health
Date:
Authors: Patricio López-Jaramillo 1 , Ramfis E Nieto-Martínez 2 , Gestne Aure-Fariñez 3 , Carlos O Mendivil 4 , Rodolfo A Lahsen 5 , Ruy L Silva-Filho 6 , Luiz A Andreotti 7 , Mónica E Manrique 8 , Miguel A Pasquel-Andrade 9 , Ignacio Rangel 10 , Maricela Vidrio 11 , Rutila Castañeda 12 , Manuela Restrepo 13 , Miguel E Pinto 14
Abstract:
To understand the status of prediabetes diagnosis and treatment in Latin America and to evaluate the use of metformin for diabetes prevention in this context.
Published: Annals of Global Health
Date:
Authors: Ramfis Nieto-Martínez 1 , Juan P González-Rivas 2 , Pablo Aschner 3 , Noël C Barengo 4 , Jeffrey I Mechanick 5
Abstract:
Type 2 diabetes (T2D) imposes a heavy burden in developing countries, requiring effective primary prevention policies. Randomized clinical trials have identified successful strategies in T2D prevention. However, translating these results to real-life scenarios and adapting to ethnocultural differences is a major challenge.